![]() |
|
|
Vol. 289, Issue 1, 321-328, April 1999
Receptor in Frog Pituitary
Melanotrope Cells Through a G Protein-Dependent Pathway1
European Institute for Peptide Research (IFRMP No. 23), Laboratory
of Cellular and Molecular Neuroendocrinology, Institut National de la
Santé et de la Recherche Médicale U413, Unité Associée
Centre National de la Recherche Scientifique, University of Rouen,
Mont-Saint-Aignan, France
Gramicidin perforated patch-clamp recordings were used to
study the effects of two
1 receptor ligands,
(+)-N-cyclopropylmethyl-N-methyl-1,4-diphenyl-1-ethyl-but-3-en-1-ylamine hydrochloride (JO 1784) and (+)-pentazocine, on the transient outward potassium current (IA) in cultured
frog melanotrope cells. (+)-Pentazocine reversibly decreased the
current amplitude in a dose-dependent manner. The effects of
(+)-pentazocine were mimicked by JO 1784 and were markedly reduced by
the
1 receptor antagonist, N,N-dipropyl-2-[4-methoxy-3-2(2-phenylethoxy)phenyl]-ethylamine monohydrochloride (NE 100). Inactivation rate of IA was
best fitted with a double exponential function, yielding time constants
of 23.7 and 112.5 ms. (+)-Pentazocine (20 µM) accelerated the current decay, decreasing the time constants to 10.7 and 59 ms, respectively. Current-voltage experiments revealed that (+)-pentazocine (20 µM) did
neither modify the open-state I/V curves nor the voltage dependence of IA. However, (+)-pentazocine
(20 µM) shifted the steady-state inactivation curve toward more
negative potentials and increased the time constant of the
time-dependent removal of inactivation. In whole-cell experiments,
internal dialysis of guanosine-5'-O-(3-thiophosphate)
(100 µM) irreversibly prolonged the response to (+)-pentazocine. In
addition, cholera toxin pretreatment (1 µg · ml
1;
12 h) suppressed the inhibition of IA
by (+)-pentazocine (20 µM). It is concluded that in frog melanotrope
cells, a cholera toxin-sensitive, G protein-dependent inhibition of
IA through a
1 receptor activation, at
least partially, underlies the excitatory effect of
ligands.
This article has been cited by other articles:
![]() |
A. Renaudo, S. L'Hoste, H. Guizouarn, F. Borgese, and O. Soriani Cancer Cell Cycle Modulated by a Functional Coupling between Sigma-1 Receptors and Cl- Channels J. Biol. Chem., January 26, 2007; 282(4): 2259 - 2267. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang and J. Cuevas {sigma} Receptor Activation Blocks Potassium Channels and Depresses Neuroexcitability in Rat Intracardiac Neurons J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1387 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Renaudo, V. Watry, A.-A. Chassot, G. Ponzio, J. Ehrenfeld, and O. Soriani Inhibition of Tumor Cell Proliferation by {sigma} Ligands Is Associated with K+ Channel Inhibition and p27kip1 Accumulation J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1105 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Aydar, C. P. Palmer, and M. B. A. Djamgoz Sigma Receptors and Cancer: Possible Involvement of Ion Channels Cancer Res., August 1, 2004; 64(15): 5029 - 5035. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang and J. Cuevas Sigma Receptors Inhibit High-Voltage-Activated Calcium Channels in Rat Sympathetic and Parasympathetic Neurons J Neurophysiol, June 1, 2002; 87(6): 2867 - 2879. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schaefer, U. F. Habenicht, M. Bräutigam, and T. Gudermann Steroidal Sigma Receptor Ligands Affect Signaling Pathways in Human Spermatozoa Biol Reprod, July 1, 2000; 63(1): 57 - 63. [Abstract] [Full Text] |
||||